Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Augmedit logo — 3D Anatomical Intelligence for Neurosurgery | Eliminating In...

Augmedit

3D Anatomical Intelligence for Neurosurgery | Eliminating Intraoperative Uncertainty | FDA Cleared & CE Marked

Founded 2018 The Netherlands The Netherlands 28 employees Seed Total: $2.75M Health Care, VR/AR

General Information

Company Name Augmedit
Founded Year 2018
Location The Netherlands The Netherlands
Founders / Decision Makers
Team member
Employees 28
Industries Health Care, VR/AR
Funding Stage Seed
Business Model B2B, SaaS, Platform
Revenue Model Subscription, Service Fee, Tiered Pricing
Social

BounceWatch is an independent company data service, not affiliated with Augmedit. To contact Augmedit, visit augmedit.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Augmedit compare?

A PDF of Augmedit and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Augmedit soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Augmedit

Augmedit, founded in 2018, is at the forefront of revolutionizing neurosurgery with its innovative approach to surgical precision. Headquartered in The Netherlands, the company is entrenched in the Health Care and VR/AR industries, aiming to eliminate intraoperative uncertainty through its slogan: "Holographic Intelligence for Neurosurgery."

Augmedit's technology offers AI-driven anatomical insights without the burden of heavy hardware, making AR visualization accessible. Their solutions, LumiNE Lite and Lumine Elite, are notable for being fully FDA cleared and CE marked. With a strong scientific foundation validated by over 20 peer-reviewed publications and 2,000 clinical cases, Augmedit positions itself as a vital extension of surgical expertise.

The company last secured a €1.00M Seed Round investment on 01 November 2022 from Revere Partners. With a strategic vision for expanding its influence across all surgical therapies, Augmedit invites potential investors to join its mission of enhancing patient outcomes by reducing surgical complexity.

Business keywords: Holographic Intelligence, Neurosurgery, Intraoperative Visualization, Augmented Reality, Mixed Reality, Medical Education, Holographic Visualization, Neuronavigation, AI-Driven Anatomical Insights, Cloud-based Surgical Support, Surgical Planning, Patient Education, Extended Reality, Spatial Computing

Services & Products

AR-based preoperative and operative care solutions
2D to 3D imaging conversion
Neurosurgical planning and visualization
Data management and patient image navigation

Target Customers

Neurosurgical staff 3D Labs Researchers CMF Surgeons Healthcare providers

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round €1.00M 1
Revere Partners
Revere Partners
01 Nov 2022
Grant €1.75M 1
European Innovation Council
European Innovation Council
14 Oct 2022

Augmedit Alternatives & Competitors

View All Alternatives
Augmedit vs
Medivis
Medivis United States

Holographic Surgical Navigation

Series A
35 employees
AI, Data Analytics
Compare Augmedit vs Medivis
Augmedit vs
XR Pediatrics
XR Pediatrics United States

We use extended reality to develop applications focused on improving the health and well-being of yo...

Grant
6 employees
Health Care, VR/AR
Compare Augmedit vs XR Pediatrics
Augmedit vs
Sira Medical
Sira Medical United States

Improving surgical planning with Augmented Reality

Seed
5 employees
Health Care, VR/AR
View all alternatives

FAQ About Augmedit

3D Anatomical Intelligence for Neurosurgery | Eliminating Intraoperative Uncertainty | FDA Cleared & CE Marked
Augmedit was founded in 2018.
Augmedit is headquartered in The Netherlands.
Augmedit operates in Health Care and VR/AR. Its work centres on Holographic Intelligence, Neurosurgery, Intraoperative Visualization and Augmented Reality. Its customers include Neurosurgical staff, 3D Labs and Researchers.
Augmedit has a B2B, SaaS and Platform business model. Its revenue comes from Subscription, Service Fee and Tiered Pricing.
Augmedit has approximately 28 employees.
Augmedit has completed 2 funding rounds, raising a total of $2.75M. The latest funding stage is Seed.
Augmedit offers: AR-based preoperative and operative care solutions, 2D to 3D imaging conversion, Neurosurgical planning and visualization, Data management and patient image navigation.
Top alternatives and competitors to Augmedit include Medivis, XR Pediatrics, Sira Medical, Proximie, Learnroll Immerse. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Augmedit and Medivis are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Augmedit, https://bouncewatch.com/company/augmedit, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout